Nuplazid approved for Parkinson's hallucinations
Monday, May 2, 2016 - 16:40
in Health & Medicine
HealthDay News Nuplazid (pimavanserin) has been approved by the U.S. Food and Drug Administration to treat hallucinations and delusions associated with Parkinson's disease.